| |SEPTEMBER 20244The market for pharma contamination control solutions in India is growing rapidly due to the enhanced concern of the quality of the drugs being manufactured. This market encompasses a wide spectrum of products and services that are aimed to minimize contamination in pharmaceutical facilities including cleanroom supplies and equipment, air and water purification systems, and instrumentation. Being one of the largest producers of generic drugs and being home to some of the most important pharmaceutical manufacturing companies, India has realized the need for effective contamination control solutions. This market's development is driven primarily by the regulatory demands from national and global organizations. These organizations require adherence to the GMP in an attempt to promote the safety, effectiveness and quality of the pharmaceutical products. Any contamination risks are costly, and may result in product recalls, and tarnished image of a company; hence forcing more pharmaceutical manufacturers to seek for efficient contamination control solutions. Another factor is the rising concern of microbial contamination which is critical in the production of sterile drugs and biotechnology products. The increase in demand biologics and sterile injectable drugs, which are prone to contamination, also drive the market growth. Also, technology improvement in the area of automation and real-time monitoring solutions has shifted the approaches to contamination control and raised the level of minimizing human factors impact. With the India's pharmaceutical industry in a progressive state, there is anticipated increase in the need for advanced contamination control systems. Keeping tabs on this market, India Pharma Outlook has shortlisted the select few companies from this sector that have exhibited an unrelenting pursuit of excellence. By proving their dedication to fulfilling customer expectations and contributing to the market's evolution through their innovative disposition, these firms are blazing a trail. We look forward to receiving your feedback and suggestions. Sudhakar Singh Editor editor@indiapharmaoutlook.comSafeguarding Drug Manufacturing Integrity Vol 2 · Issue 05 - 2 · SEPTEMBER 2024Publisher Alok ChaturvediEditor Hridkamal RoyAssistant Editor Roshan AktharEditorial TeamViswanathan ANalini BramhanapalliThiruamuthan TK Senior Designer Rajesh R B Visualizer Hari Priya V Aruna Kumari KAdvertising QueriesDivyajit Rahul KumarGM Sales & MarketingRavi Kalgisales@indiapharmaoutlook.com Editorial Querieseditor@indiapharmaoutlook.comCirculation Manager Magendran PerumalMagazine Price is Rs. 150 per issuePrinted and Published By Alok Chaturvedi on behalf of Silicon Media Technologies Pvt. Ltd. and Printed at Executive Prints - 113/7, Ground floor, Old madras road, Halasuru, Bangalore 560008 and Published At No. 124, 2nd Floor, Surya Chambers, Old Airport Road, Murugeshpalya, Bangalore-560017.Publisher Alok ChaturvediCopyright © 2024 Silicon Media Technologies Pvt. Ltd., All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher.
< Page 3 | Page 5 >